The JV intends to construct a plant to manufacture non-penicillin and non-cephalosporin Rx drugs and other drugs that are categorised as over-the-counter (OTC) products in Russia. It has also been contemplated to transfer 100 per cent interest in the CJSC Olifen (engaged in production of pharmaceutical substances) being held by Diod to the JV company, subject to due diligence.
25000
0
29000
0
3902
7284
2499
3899
999
2499
179
299
135
399
25000
0
6720
0
29000
0
1399
2999
685
950
3149
6299